Financial Performance - Q4 2023 - Mettler-Toledo's Q4 net sales decreased by 12% to $934.992 million[25], with a local currency sales decline of 13%[3, 25] - The adjusted operating margin for Q4 was 30.1%, a decrease of 380 basis points[3, 25] - Adjusted EPS for Q4 was $9.40, a decrease of 22%[3, 25] Financial Performance - Full Year 2023 - Full year net sales decreased by 3% to $3.788 billion[5, 26], with a local currency sales decline of 3%[5, 26] - The adjusted operating margin for the full year was 30.4%[26] - Adjusted EPS for the full year was $38.03, a decrease of 4%[26] Sales by Geography - Q4 2023 - Americas sales increased by 9% in local currency to $428 million[4] - Europe sales decreased by 16% in local currency to $260 million[4] - Asia/ROW sales decreased by 18% in local currency to $273 million[4] Sales by Geography - Full Year 2023 - Americas sales decreased by 1% in local currency to $1.568 billion[5] - Europe sales decreased by 2% in local currency to $1.015 billion[5] - Asia/ROW sales decreased by 5% in local currency to $1.205 billion[5] Sales by Product - Q4 2023 - Laboratory sales decreased by 18% in local currency to $513 million[7] - Industrial sales decreased by 7% in local currency to $370 million[7] - Food sales increased by 9% in local currency to $51 million[7] Sales by Product - Full Year 2023 - Laboratory sales decreased by 7% in local currency to $2.069 billion[10] - Industrial sales decreased by 1% in local currency to $1.490 billion[10] - Food sales increased by 27% in local currency to $229 million[10]

Financial Performance - Net sales for Q3 2023 were $942.5 million, a decrease of 4% compared to $985.8 million in Q3 2022, while net sales for the nine months ended September 30, 2023 remained flat at $2.9 billion compared to the same period in 2022[97]. - Gross profit margin for Q3 2023 was 59.4%, slightly up from 59.3% in Q3 2022, and for the nine months ended September 30, 2023, it was 59.2%, compared to 58.6% in the same period of 2022[105]. - Total net sales in U.S. operations decreased by 5% to $388,011 thousand for the three months ended September 30, 2023, and by 2% to $1,151,517 thousand for the nine months ended September 30, 2023 compared to 2022[115]. - Total net sales in Swiss operations were flat in U.S. dollars for the three months ended September 30, 2023, while net sales to external customers increased by 23%[117]. - Total net sales in Chinese operations decreased by 25% to $232,404 thousand for the three months ended September 30, 2023, and by 12% to $767,572 thousand for the nine months ended September 30, 2023 compared to 2022[123]. - Total net sales in other operations increased by 12% to $180,616 thousand for the three months ended September 30, 2023, and by 10% to $517,406 thousand for the nine months ended September 30, 2023 compared to 2022[126]. Expenses and Costs - Research and development expenses increased by 5% in U.S. dollars for Q3 2023, totaling $46.1 million, and were 4.9% of net sales, compared to 4.5% in Q3 2022[107]. - Selling, general and administrative expenses decreased by 7% in U.S. dollars for Q3 2023, amounting to $217.4 million, and represented 23.1% of net sales, down from 23.7% in Q3 2022[108]. - Interest expense rose to $20.3 million in Q3 2023 from $14.5 million in Q3 2022, reflecting higher variable interest rates[110]. - Restructuring charges increased to $7.4 million in Q3 2023 from $2.0 million in Q3 2022, primarily due to employee-related costs[111]. Market Conditions - The company expects reduced sales in China for the remainder of 2023 due to significantly deteriorating market demand[98]. - Net sales of laboratory-related products, which accounted for approximately 55% of total net sales, decreased by 8% in U.S. dollars for Q3 2023[102]. - Net sales of industrial-related products decreased by 5% in U.S. dollars for Q3 2023, while service revenue increased by 9% in U.S. dollars for the same period[101]. Tax and Profitability - The reported tax rate for Q3 2023 was 19.7%, slightly down from 20.0% in Q3 2022[113]. - Segment profit in U.S. operations decreased by $3.2 million for the three months but increased by $14.8 million for the nine months ended September 30, 2023, due to margin expansion and cost savings initiatives[116]. - Segment profit in Chinese operations decreased by $39.5 million for the three months and by $28.9 million for the nine months ended September 30, 2023, primarily due to lower sales volume and unfavorable currency translation[125]. Cash Flow and Capital Expenditures - Cash provided by operating activities totaled $684.4 million during the nine months ended September 30, 2023, an increase from $555.4 million in the corresponding period in 2022[131]. - Capital expenditures totaled $72.9 million for the nine months ended September 30, 2023, down from $89.2 million in the corresponding period in 2022[132]. Debt and Financing - As of September 30, 2023, total debt amounted to $2.108 billion, with long-term debt at $1.929 billion[137]. - The company has $545.2 million of additional borrowings available under its Credit Agreement and $69.7 million in cash and cash equivalents[138]. - The company issued $150 million in 5.45% Senior Notes in March 2023, maturing in March 2033, to refinance existing indebtedness[141]. - The company amended its Credit Agreement in May 2023 to replace LIBOR with SOFR as the interest rate benchmark[139]. - The company was in compliance with its debt covenants as of September 30, 2023[140]. Share Repurchase Program - The company has $2.7 billion remaining for its share repurchase program as of September 30, 2023, having repurchased 31.5 million shares since the program's inception in 2004[144][145]. - During the nine months ended September 30, 2023, the company spent $724 million on share repurchases at an average price of $1,388.54 per share[145]. Currency Impact - A 1% strengthening of the Swiss franc against the euro is estimated to reduce earnings before tax by approximately $2.0 million to $2.3 million annually[147]. - A 1% weakening of the Chinese renminbi against the U.S. dollar is estimated to reduce earnings before tax by approximately $3.3 million to $3.6 million annually[148]. - A 5% weakening of the U.S. dollar against the currencies in which the company's debt is denominated would increase the reported U.S. dollar value of debt by approximately $34.1 million[149].

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (State or other jurisdiction of (I.R.S Employer Identification No.) incorporation or organization) 1900 Polaris Parkway Columbus, OH 43240 and Im Langacher, P.O. Box MT-100 CH 8606 Greifensee, Switzerland 1-614-438-4511 and +41-44-944-22-11 ________________________________________________________________________________ (Registrant's telephone number, including area code) not applicable ______________________ ...

Local currency sales + 2% Adjusted Operating Profit Adjusted EPS Sales by Geography Note: Local currency (LC) sales excludes foreign exchange impact. Sales by Product Area 6 Q2 Local Currency Sales Growth Lab (54% of total sales) Industrial (40%) Food Retail (6%) Total (100%) 13% 9% 3% 10% -3% 6% 17% 2% 2022 2023 Note: Local currency (LC) sales excludes foreign exchange impact. Sales by Product Area 7 YTD Local Currency Sales Growth Lab (55% of total sales) Industrial (39%) Food Retail (6%) Total (100%) 15% ...

Mettler-Toledo International Inc. (NYSE:MTD) Q2 2023 Earnings Conference Call July 27, 2023 4:30 PM ET Company Participants Adam Uhlman - Head-Investor Relations Patrick Kaltenbach - Chief Executive Officer Shawn Vadala - Chief Financial Officer Conference Call Participants Daniel Arias - Stifel Jack Meehan - Nephron Research Derik de Bruin - Bank of America Patrick Donnelly - Citigroup Vijay Kumar - Evercore Matthew Sykes - Goldman Sachs Catherine Schulte - Baird Joshua Waldman - Cleveland Research Rachel ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) (Exact name of registrant as specified in its charter) (State or other jurisdiction of (I.R.S Employer Identification No.) 1900 Polaris Parkway Columbus, OH 43240 and Im Langacher, P.O. Box MT-100 CH 8606 Greifensee, Switzerland 1-614-438-4511 and +41-44-944-22-11 ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2023, ...

Safe Harbor Statement Summary Comments – Q1 2023 + 7% + 10% Q1 Highlights Sales by Geography Q1 Local Currency Sales Growth Note: Local currency (LC) sales excludes foreign exchange impact. Sales by Product Area 5 Q1 Local Currency Sales Growth Lab (56% of total sales) Industrial (38%) Food Retail (6%) Total (100%) 18% 12% -14% 14% 5% 7% 36% 7% 2022 2023 Note: Local currency (LC) sales excludes foreign exchange impact. Earnings Webcast May 5, 2023 Statements in this presentation which are not historical fac ...

Mettler-Toledo International Inc. (NYSE:MTD) Q4 2022 Earnings Conference Call February 10, 2023 8:30 AM ET Company Participants Patrick Kaltenbach - President, Chief Executive Officer Shawn Vadala - Chief Financial Officer Adam Uhlman - Head of Investor Relations Conference Call Participants Josh Waldman - Cleveland Research Dan Arias - Stifel Jack Meehan - Nephron Research Vijay Kumar - Evercore ISI Tim Daley - Wells Fargo Matt Sykes - Goldman Sachs Brandon Couillard - Jefferies Catherine Schulte - Baird ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-13595 Mettler-Toledo International Inc. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorp ...

Mettler-Toledo International Inc. (NYSE:MTD) Q3 2022 Earnings Conference Call November 3, 2022 5:00 PM ET Company Participants Adam Uhlman - Investor Relations Patrick Kaltenbach - Chief Executive Officer Shawn Vadala - Chief Financial Officer Mary Finnegan - Investor Relations Conference Call Participants Josh Waldman - Cleveland Research Jordan Adler - Evercore ISI Tim Daley - Wells Fargo Alonso Garcia - UBS Matt Sykes - Goldman Sachs Operator Good afternoon. My name is Audra, and I will be your conferenc ...